Email this page to a colleague   Print this page

Subscribe

Plasticell publication describes combinatorial methods in stem cell research

Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has announced the publication of a book chapter which presents the case for combinatorial methods in stem cell research.

The chapter by Dr. Yen Choo, Plasticell’s founder, is entitled ‘Use of Combinatorial Screening to Discover Protocols That Effectively Direct the Differentiation of Stem Cells’ and appears in ‘Stem Cell Research and Therapeutics’ (Y. Shi and D.O. Clegg, Eds), published by Springer Science & Business Media.

The publication draws a parallel between stem cell differentiation and protein engineering which is used to produce commercially useful molecules such as zinc fingers and antibodies. While both disciplines rely on empirical experimentation to discover optimal biological solutions, the more mature field of protein engineering has progressed largely due to combinatorial screening methods. It is argued that similar cell biology methods could revolutionize the stem cell field.

Plasticell’s ‘Combinatorial Cell Culture’ (Combicult™) is a combinatorial screening method for cell biology with applications in stem cell differentiation. The method allows cost- and time- efficient testing of very large numbers of combinations of cell culture variables, identifying new protocols for efficient differentiation of stem cells.

About Plasticell

Plasticell is a biotechnology company that specialises in using massively parallel screens to differentiate stem cells. The company's proprietary technology, Combinatorial Cell Culture™ (CombiCult™), allows testing of cell culture variables in random combinations to discover optimal laboratory protocols for the differentiation of adult or pluripotent stem cells.

Plasticell provides services to, and forms strategic alliances with, industry partners to produce high value cell lines and culture media for drug discovery and cell therapy applications.

For more information visit Plasticell's website: www.plasticell.co.uk

For confidential technical enquiries please contact Dr Lilian Hook on +44 7811 168 177,
or email: lilian@plasticell.co.uk

For media enquiries, please contact Tristan Jervis on +44 207 861 3019, or e-mail: t.jervis@defacto.com